Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey Stauffer

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cell Death & Disease|September 7, 2021
A novel mouse model of PMS2 founder mutation that causes mismatch repair defect due to aberrant splicingKajal Biswas, Martin Couillard, Luca Cavallone, et al.
Human Molecular Genetics|June 9, 2012
Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assayKajal Biswas, Ranabir Das, Julie M Eggington, et al.
Nature Communications|August 9, 2016
Synthetic viability by BRCA2 and PARP1/ARTD1 deficienciesXia Ding, Arnab Ray Chaudhuri, Elsa Callen, et al.
Human Mutation|December 14, 2020
Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancerTeresa Sullivan, Eswary Thirthagiri, Chan-Eng Chong, et al.
Cancers|July 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in NeuroblastomaStacey Stauffer, Jacob S Roth, Edjay R Hernandez, et al.
Molecular Cancer Therapeutics|December 4, 2025
Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancerHannah E Price, Stacey Stauffer, Hyun Lee, et al.
Cell Death & Disease|June 16, 2017
Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruptionStefan Meyer, Adam Stevens, Roberto Paredes, et al.
Human Mutation|June 28, 2022
Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordomaBing Xia, Kajal Biswas, Tzeh K Foo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E Hebron, Xiaolin Wan, Jacob S Roth, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cell Death & Disease|September 7, 2021
A novel mouse model of PMS2 founder mutation that causes mismatch repair defect due to aberrant splicingKajal Biswas, Martin Couillard, Luca Cavallone, et al.
Human Molecular Genetics|June 9, 2012
Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assayKajal Biswas, Ranabir Das, Julie M Eggington, et al.
Nature Communications|August 9, 2016
Synthetic viability by BRCA2 and PARP1/ARTD1 deficienciesXia Ding, Arnab Ray Chaudhuri, Elsa Callen, et al.
Human Mutation|December 14, 2020
Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancerTeresa Sullivan, Eswary Thirthagiri, Chan-Eng Chong, et al.
Cancers|July 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in NeuroblastomaStacey Stauffer, Jacob S Roth, Edjay R Hernandez, et al.
Molecular Cancer Therapeutics|December 4, 2025
Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancerHannah E Price, Stacey Stauffer, Hyun Lee, et al.
Cell Death & Disease|June 16, 2017
Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruptionStefan Meyer, Adam Stevens, Roberto Paredes, et al.
Human Mutation|June 28, 2022
Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordomaBing Xia, Kajal Biswas, Tzeh K Foo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E Hebron, Xiaolin Wan, Jacob S Roth, et al.
Pageof 3